Form 144 insider plans 60,000 share sale

An insider has filed a Form 144 indicating an intention to sell 60,000 shares of common stock of issuer XERS through Morgan Stanley Smith Barney LLC on or around 01/08/2026, with the shares listed on the NASDAQ.

Rhea-AI Filing Summary

An insider has filed a Form 144 indicating an intention to sell 60,000 shares of common stock of issuer XERS through Morgan Stanley Smith Barney LLC on or around 01/08/2026, with the shares listed on the NASDAQ. The filing cites an aggregate market value of $432,600.00 for this planned sale.

The shares to be sold were acquired as restricted stock units from the issuer on 01/31/2021. As context, the filing notes that there were 165,924,289 shares of this class outstanding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for XERS disclose?

The Form 144 discloses that an insider intends to sell 60,000 shares of XERS common stock, with an aggregate market value of $432,600.00, under Rule 144.

When are the XERS shares expected to be sold under this Form 144?

The filing lists an approximate date of sale of 01/08/2026 for the planned sale of 60,000 XERS common shares on the NASDAQ.

How were the 60,000 XERS shares in the Form 144 acquired?

The 60,000 shares were acquired as restricted stock units from the issuer on 01/31/2021, with the same date shown as the payment date and the nature of payment noted as N/A.

What is the role of the broker in this XERS Form 144 filing?

The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker to handle the planned sale of 60,000 XERS common shares on the NASDAQ.

How many XERS shares of this class are outstanding according to the Form 144?

The Form 144 notes that there are 165,924,289 shares of the relevant class of XERS common stock outstanding.

Does the XERS Form 144 mention recent sales in the past three months?

The excerpt includes a section for securities sold during the past 3 months, but no specific past sales data is provided in the available content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/08/2026 - 04:22 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002031695
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	XERIS BIOPHARMA HOLDINGS INC
SEC File Number	001-40880
Address of Issuer	1375 West Fulton Street, Suite 1300 Chicago ILLINOIS 60607
Phone	8444455704
Name of Person for Whose Account the Securities are To Be Sold	KEVIN MCCULLOCH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	60000	432600.00	165924289	01/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2021	Restricted Stock Units	Issuer			60000	01/31/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 01/31/2021 through 01/03/2025.
Date of Notice	01/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/04/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kevin McCulloch
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)